company

ALGIPHARMA HOLDING AS

1337 SANDVIKA

Return on Equity
−0,06 %
Current Ratio
746,49
Debt-to-Equity Ratio
0,7
Key figures (NOK)2022
Revenue0
Net Income−52 000
Total Assets143 621 000
Total Equity84 267 000
Income (NOK)2022
Revenue0
Expenditure52 000
Operating Profit−52 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−52 000
Tax0
Net Income−52 000
Balance (NOK)2022
Total Fixed Assets93 606 000
Total Current Assets50 015 000
Total Assets143 621 000
Total Retained Equity−52 000
Total Equity84 267 000
Total Long-Term Debt59 287 000
Total Current Debt67 000
Total Equity and Debt143 621 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure52 000
Operating Profit−52 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−52 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets93 606 000
Total Fixed Assets93 606 000
Stock0
Total Investments0
Cash, Bank0
Total Current Assets50 015 000
Total Assets143 621 000
Total Equity84 267 000
Short-Term Group Debt47 000
Total Long-Term Debt59 287 000
Creditors5 000
Unpaid Taxes0
Dividends0
Other Current Debt15 000
Total Current Debt67 000
Total Equity and Debt143 621 000
Financial indicators2022
Return on Equity−0,06 %
Debt-to-Equity Ratio0,7
Operating Profit Margin-
Current Ratio746,49
Quick Ratio746,49
Equity Ratio0,59
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English